Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129111) titled 'Prediction of Lymph Node Metastasis Risk Using Ultrasound Radiomics and Exploration of Its Underlying Mechanisms' on July 31.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: chongqing university cancer hospital
Condition:
Breast cancer with axillary lymph node metastasis
Intervention:
Gold Standard:Pathological result of lymph node biopsy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-31
Target Sample Size: Target condition:100;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.c...